國際超音波醫學會對於 NIPT 提出聲明

 

• Screening strategies based on individual risk calculated from maternal age and nuchal translucency measurement and/or maternal serummarkers and/or other ultrasound markers in the first trimester (defined by the conventional crown–rump length range of 45–84 mm). At the moment, ISUOG endorses this strategy. Following such screening, women can be offered a choice, according to their calculated individual risk, of having no further testing, undergoing NIPT, or undergoing invasive testing.

• NIPT may be discussed as an alternative to invasive testing following an abnormal result on combined screening or offered to patients who are not sufficiently reassured by an ‘intermediate risk’ result.